´Ý±â
TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Ű¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæÃ»Áö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.
Home > ÀüÁ¦Ç°º¸±â > NGS °ü·Ã > mRNA-Seq (Single cell) > [Cancer Research] Cancer single cell analysis

[Cancer Research] Cancer single cell analysis

-



Two RNA-seq approaches reveal resident memory T cells hold the power to reverse liver fibrosis

°£ ¼¶À¯Áõ (liver fibrosis)´Â ºñ°¡¿ªÀû Áúȯ Áß Çϳª·Î ¾Ë·ÁÁ® ÀÖÁö¸¸, ÃÖ±Ù ÀÌ ÁúȯÀÌ Ä¡·áµÉ ¼ö ÀÖÀ½À» ÇÑ ¿¬±¸¿¡¼­ ½Ã»çÇÏ¿´´Ù. Nature Communications ÇÐȸÁö¿¡ ¹ßÇ¥µÈ ¿¬±¸¿¡ µû¸£¸é, Koda et al.Àº °£ ¼¶À¯ÁõÀ» ÇØ°áÇÒ »õ·Î¿î ¸¶¿ì½º ¸ðµ¨À» °³¹ßÇÏ°í ±× Æ¯¼ºÀ» ºÐ¼®ÇÏ¿´´Ù. ÀÌ »õ·Î¿î ¸¶¿ì½º ¸ðµ¨°ú single-cell RNA-seq (scRNA-seq), bulk mRNA-seq ºÐ¼® °á°ú¸¦ ÅëÇÕÇÏ¿© ±â´É ºÐ¼®À» ÁøÇàÇÏ¿´À¸¸ç, À̸¦ ÅëÇØ ƯÁ¤ T ¼¼Æ÷°¡ hepatic stellate cellÀ» À¯ÀÎÇÏ°í ¼¼Æ÷ÀÚ¸ê»ç (apoptosis)¸¦ À¯µµÇØ °£ ¼¶À¯ÁõÀ» À¯¹ßÇÏ´Â ÁÖ¿ä ¿äÀÎÀÌ µÈ ´Ù´Â °ÍÀ» È®ÀÎÇÏ¿´´Ù.

Inflammation from NAFLD and NASH leads to liver fibrosis
ºñ¾ËÄڿüº Áö¹æ°£ Áúȯ (non-alcoholic fatty liver disease, NAFLD)Àº Àü ¼¼°èÀûÀ¸·Î ¸¸¼º °£ ÁúȯÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ²ÅÈù´Ù. NAFLD´Â °£À» ÀÌ·ç´Â ÁÖ¿ä ¼¼Æ÷ÀÎ hepatocyte¿¡¼­ Áö¹æÀ» °úµµÇÏ°Ô ÃàÀûÇÏ´Â Áõ»óÀ» º¸ÀδÙ. ÀÌ·¯ÇÑ Áö¹æÁõÀº Á¤µµ¿¡ µû¶ó ´Ü¼ø Áö¹æÁõºÎÅÍ °£¿± (lobe)¿¡ ¿°ÁõÀÌ »ý±ä »óÅÂÀÎ ºñ¾ËÄڿüº Áö¹æ°£¿° (non-alcoholic steatohepatitis, NASH)±îÁö ´Ù¾çÇÑ »óÅ·ΠºÐ·ùÇÒ ¼ö ÀÖ´Ù. NAFLD ¹× NASH ȯÀÚµéÀº °£ ¼¶À¯ÁõÀÌ ÁøÇàµÇ¾î °£ º´º¯ (cirrhosis)³ª °£¾ÏÀ¸·Î ¹ßÀüÇÒ ¼ö ÀÖ´Ù.

ºÐÀÚÇÐÀû Ãø¸é¿¡¼­ º¸¸é, NAFLD ¹× NASH·Î ÀÎÇÑ ¹Ýº¹ÀûÀÎ °£¼¼Æ÷ÀÇ ÆÄ±«´Â ¸é¿ª ¼¼Æ÷°¡ ħÅõÇÏ¿© ´Ù¾çÇÑ chemokine, cytokineÀ» ¹æÃâÇÏ´Â ¿°Áõ ȯ°æÀ» Á¶¼ºÇÑ´Ù. ÀÌ·¯ÇÑ chemokine°ú cytokineÀº hepatic stellate cell¸¦ Ȱ¼ºÈ­ ½ÃÄÑ °£ ¼¶À¯È­ÀÇ ÁÖ¿ä ¿äÀÎÀÌ µÈ´Ù (Âü°í ¹®Çå: Mechanisms of hepatic stellate cell activation).

A new mouse model for liver fibrosis resolution: the RES model
°£ ¼¶À¯ÁõÀ» ȸº¹½Ãų ¼ö ÀÖ´Â ±âÀüÀ» ¿¬±¸Çϱâ À§ÇØ, Koda et al.Àº ¸ÕÀú °£ ¼¶À¯ÁõÀÌ È¸º¹µÇ´Â °ÍÀ» °üÂûÇÒ ¼ö ÀÖ´Â ½ÇÇè ¸ðµ¨ÀÌ ÇÊ¿äÇß´Ù. µû¶ó¼­, ¸¶¿ì½º¿¡ Áö¼ÓÀûÀ¸·Î °íÁö¹æ°ú °íÄÝ·¹½ºÅ×·Ñ ½ÄÀÌ (high fat, high cholesterol diet, HFHC)¸¦ ±Þ¿©ÇÏ¿© NASH¸¦ À¯µµ ÇÏ¿´°í, 24ÁÖ ÈÄ¿¡´Â Á¤»óÀû ¼ººÐÀÇ ½ÄÀÌ (normal diet, ND)·Î ¹Ù²Ù¾î RES modelÀ» Á¦ÀÛÇß´Ù. RES mice´Â HFHC ½ÄÀÌ µ¿¾È ¸íÈ®ÇÑ °£ ¼¶À¯Áõ Áõ»óÀ» º¸¿´À¸³ª, Á¤»ó ½ÄÀÌ·Î ÀüȯÇÑ 8ÁÖ ÈÄ¿¡´Â Á¤»óÀûÀÎ »óÅ·Πȸº¹µÇ¾ú´Ù.


±×¸² 1. ND, HFHC¿Í Á¤»ó ½ÄÀÌ·Î ÀüȯÇÑ 8ÁÖ ÈÄÀÇ RES ¸¶¿ì½ºÀÇ °£
Image adapted from Koda et al. 2021, Nat. Commun. under a CC BY 4.0 license.

Uncovering a mechanism for reversal of liver fibrosis using both single-cell and bulk mRNA-seq
Koda et al.Àº ND (Á¤»ó ½ÄÀÌ)¸¦ ±Þ¿©ÇÑ ¸¶¿ì½ºº¸´Ù RES ¸¶¿ì½º¿¡¼­ CD8+ T ¼¼Æ÷°¡ ³ô°Ô ¹ßÇöÇÏ´Â °ÍÀ» °üÂûÇÏ¿´À¸¸ç, À̸¦ ÅëÇØ ÀÌ ¼¼Æ÷ Áý´ÜÀÌ °£ ¼¶À¯ÁõÀ» ȸº¹½ÃŰ´Â µ¥ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖ´Ù´Â °¡¼³À» ¼¼¿ü´Ù. µû¶ó¼­, ND, HFHC, RES ¸¶¿ì½º¸¦ scRNA-seq ºÐ¼®ÇÏ¿© CD8+ ¼¼Æ÷¸¦ 17°³ÀÇ cluster·Î ±×·ìÈ­ÇÏ¿´°í, 4°³ÀÇ ÁÖ¿ä CD8+ T ¼¼Æ÷ ÇÏÀ§ Áý´ÜÀ¸·Î ºÐ·ùÇÏ¿´´Ù. Èï¹Ì·Ó°Ôµµ, RES ¸¶¿ì½º¿¡¼­´Â CD8+ T ¼¼Æ÷ÀÇ Æ¯Á¤ ÇÏÀ§ Áý´Ü¿¡¼­ resident memory T ¼¼Æ÷ (trm cell)°¡ ´Ù¼ö ¸ð¿© ÀÖ´Â ¾ç»óÀ» º¸¿´´Ù.


±×¸² 2. ND, HFHC, RES ¸¶¿ì½º¿¡¼­ ÃßÃâÇÑ liver CD8+ T ¼¼Æ÷ÀÇ UMAP projection
The clusters within the trm subsets for each mouse model are outlined. Image adapted Koda et al. 2021, Nat. Commun. under a CC BY 4.0 license.

Trm ¼¼Æ÷°¡ °£ ¼¶À¯Áõ ȸº¹¿¡ ¾î¶»°Ô ±â¿©ÇÏ´Â Áö¸¦ º¸´Ù ÅëÂû·Â ÀÖ°Ô ºÐ¼®Çϱâ À§ÇØ, Koda et al.Àº SMART-Seq¢ç v4 Ultra¢ç Low Input RNA Kit for Sequencing¸¦ ÀÌ¿ëÇØ ND, HFHC, RES ¸¶¿ì½ºÀÇ CD8+ T ¼¼Æ÷ÀÇ ÇÏÀ§ Áý´Ü¿¡¼­ Àü»çü¸¦ ºñ±³ ºÐ¼® ÇÏ¿´´Ù. Bulk mRNA-seq»Ó ¾Æ´Ï¶ó scRNA-seq µ¥ÀÌÅ͸¦ ÇÔ²² ÅëÇÕÇÏ¿©, HFHC¿Í RES ¸¶¿ì½º ¸ðµÎ¿¡¼­ trm ¼¼Æ÷°¡ cytotoxic ¹× chemotactic mediator¸¦ upregulationÇÑ´Ù´Â °ÍÀ» È®ÀÎÇÏ¿´´Ù. ±× Áß Æ¯È÷ Ccl5´Â ³ô°Ô upregulationµÈ À¯ÀüÀÚ·Î, ÀÌ ºÐºñµÈ À¯ÀüÀÚ¿Í ¹ÝÀÀÇÏ´Â CCR5 receptor°¡ °£ ¼¶À¯Áõ »óÅÂÀÇ hepatic stellate cell¿¡¼­´Â ¹ßÇöµÇÁö ¾Ê¾ÒÁö¸¸, °£ ¼¶À¯Áõ¿¡¼­ ȸº¹ÇÏ´Â °úÁ¤¿¡¼­ ¹ßÇöµÇ¾ú±â ¶§¹®¿¡ ÁÖ¿ä Ÿ°ÙÀÌ µÇ¾ú´Ù. Àü»çü ºÐ¼® °úÁ¤À¸·Î È®ÀÎµÈ °ÍÀ» ¹ÙÅÁÀ¸·Î, Koda et al.Àº trm ¼¼Æ÷°¡ CCR5¿¡ ÀÇÁ¸ÇÏ¿© hepatic stellate cellÀ» ƯÀÌÀûÀ¸·Î À¯ÀÎÇÏ°í ¼¼Æ÷ »ç¸ê (apoptosis)¸¦ À¯µµÇÔÀ¸·Î½á °£ ¼¶À¯ÁõÀ» ȸº¹½ÃŲ´Ù´Â ¿¬±¸¸¦ ¼öÇàÇÏ¿´´Ù.

¿¬±¸ÀÚµéÀº scRNA-seqÀ̳ª bulk RNA-seq Áß Çϳª¸¦ ¼±ÅÃÇÏ´Â °ÍÀÌ ¾Æ´Ñ µÎ Á¢±Ù ¹æ½ÄÀ» ¸ðµÎ Ȱ¿ëÇÔÀ¸·Î½á ¾î¶² ¼¼Æ÷ À¯ÇüÀ» ÁýÁßÀûÀ¸·Î ºÐ¼®ÇÒ °ÍÀÎÁö¸¦ ¾Ë ¼ö ÀÖÀ» »Ó ¾Æ´Ï¶ó, Àü»çü¸¦ º¸´Ù ´õ ±íÀº ¼öÁØÀ¸·Î ޱ¸ÇÒ ¼ö ÀÖ´Ù. Koda et al.ÀÇ ¿¬±¸¿¡¼­µµ ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ±×°£ Ä¡·áÇÒ ¼ö ¾ø´Ù°í ¾Ë·ÁÁ® ÀÖ´ø NAFLD, NASH ¹× °£ ¼¶À¯ÁõÀÇ Ä¡·áÀÇ °¡´É¼ºÀ» ¿­°í »ý¹°ÇÐÀû ±âÀü ¿¬±¸¸¦ º¸´Ù ¹ßÀü½Ãų ¼ö ÀÖ¾ú´Ù.

[¿ø¹®] Two RNA-seq approaches reveal resident memory T cells hold the power to reverse liver fibrosis
[Âü°í¹®Çå]
- Koda, Y. et al. CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat Commun 12, 4474 (2021).
- Tsuchida, T., Friedman, S. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14, 397-411 (2017).